Liraglutide vs Pembrolizumab

## Liraglutide vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Liraglutide** and **Pembrolizumab**.

## Mechanism of Action

**Liraglutide**: GLP-1 receptor agonist enhancing insulin secretion.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Liraglutide — 13 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Liraglutide — Protein; Pembrolizumab — Antibody.